Click a link below to view the mailing archive as if it had been sent to you.
| 2017-08-31 12:15 | | Incyte, Merck build case for skin cancer combo and more... |
| 2017-08-31 00:15 | | Novartis CEO's Dilemma: Is $475,000 Too Much For A Leukemia Breakthrough? Or Is It Not Enough? and more... |
| 2017-08-30 12:15 | | Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission and more... |
| 2017-08-30 00:15 | | Managing Revenue Growth (And Contraction) In Big Pharma: What Have We Learned In The Last 10 Years? and more... |
| 2017-08-29 12:15 | | Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? and more... |
| 2017-08-29 00:15 | | Rise of MSLs: Medical professionals stand in for sales representatives on complex drug launches and more... |
| 2017-08-28 12:15 | | Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy and more... |
| 2017-08-28 00:15 | | 3 Biotech Stocks That Could Soar in September and more... |
| 2017-08-27 00:15 | | Upcoming events – GSK’s shingles panel and Axovant takes on Alzheimer’s and more... |
| 2017-08-26 12:15 | | FDA clears Novo Nordisk's diabetes drug to reduce cardiovascular risk |
| 2017-08-25 12:15 | | Pfizer's hunt for new Manhattan HQ lands on snazzy Spiral skyscraper: report and more... |
| 2017-08-25 00:15 | | States Take on Drug Price Transparency, Gouging and more... |
| 2017-08-24 12:15 | | EMA and FDA will now share trade secrets, allowing both regulators to act on each other’s inspection reports and more... |
| 2017-08-24 00:15 | | Medtronic Hit by High Demand for Diabetes Devices and more... |
| 2017-08-23 12:15 | | New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’ and more... |
| 2017-08-23 00:15 | | Bidders line up for Teva's women's health unit in potential $2B sale and more... |
| 2017-08-22 12:15 | | 3 Most Promising Cancer Drugs in Late-Stage Development and more... |
| 2017-08-21 12:15 | | Personal turf is ‘out,’ community workplaces are ‘in’ at the new Roche neighborhood and more... |
| 2017-08-20 12:15 | | Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant and more... |
| 2017-08-19 12:15 | | An analysis of 2017 first half for pharmaceutical industry and more... |
| 2017-08-19 00:15 | | The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia and more... |
| 2017-08-18 12:15 | | Remicade Is a Litmus Test for PBMs and more... |
| 2017-08-18 00:15 | | Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza and more... |
| 2017-08-17 12:15 | | The decade's top 10 patent losses, worth a whopping $915B in lifetime sales and more... |
| 2017-08-17 00:15 | | FDA Warning Letters: First Half of 2017 Trends and more... |
| 2017-08-16 12:15 | | New study of FDA cites the flaws behind rapid-fire cancer drug OKs and more... |
| 2017-08-16 00:15 | | Why Gilead Sciences Might Not Make an Oncology Acquisition |
| 2017-08-15 12:15 | | After a slow start, Novartis finally gains market traction with heart drug Entresto and more... |
| 2017-08-15 00:15 | | Why Merck's CEO Needn't Worry About Trump's Drug Pricing Tweet and more... |
| 2017-08-14 12:15 | | Merck CEO Ken Frazier resigns from Trump council in protest, and the president swiftly bites back and more... |
| 2017-08-13 12:15 | | How Intuitive Surgical, Inc. Makes Most of Its Money and more... |
| 2017-08-13 00:15 | | Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks? and more... |
| 2017-08-12 12:15 | | Positive signs from Valeant, market rewards it and more... |
| 2017-08-11 12:15 | | Trump says he will declare opioid crisis a national emergency and more... |
| 2017-08-11 00:15 | | The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results and more... |
| 2017-08-10 12:15 | | Teva’s alarming financial situation makes it vulnerable to takeover attempts by PEs and investment funds and more... |
| 2017-08-10 00:15 | | Opioid drugmakers may have to slash production under new DEA proposal and more... |
| 2017-08-09 12:15 | | Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff and more... |
| 2017-08-09 00:15 | | Serious medical device recalls nearly doubled in Q2 and more... |
| 2017-08-08 12:15 | | Amgen Remains A Standout Among Biotechs and more... |
| 2017-08-08 00:15 | | Kaleo launches program to give Auvi-Q allergy devices to schools and more... |
| 2017-08-07 12:15 | | Lilly's turn to pain gathers momentum and more... |
| 2017-08-07 00:15 | | The difficult search for the next Teva CEO and more... |
| 2017-08-06 00:15 | | Aeterna Zentaris claims it booted CEO and then discovered a plot to grab control of its lead asset and more... |
| 2017-08-05 12:15 | | Can Pharma Influence Physician Prescribing? Unleashing New Data Using Prostate Cancer Drugs and more... |
| 2017-08-05 00:15 | | Jury finds Martin Shkreli guilty on 3 counts of securities fraud — and he’s ‘delighted’ |
| 2017-08-04 12:15 | | Gilead Could Be Making An Acquisition — But It's Not What You Think and more... |
| 2017-08-04 00:15 | | Embattled Teva slashes staff, manufacturing facilities and more... |
| 2017-08-03 12:15 | | Sanofi shifts focus to internal R&D as it preps an end to a stunningly effective Regeneron alliance and more... |
| 2017-08-03 00:15 | | Pharma tightens its belt on jobs in 2016 as markets fall and more... |
| 2017-08-02 12:15 | | CVS formulary knocks Lilly, BI's Jardiance in favor of J&J's Invokana and more... |
| 2017-08-02 00:15 | | Expecting Big Pharma buyers to come running after weakened AstraZeneca? Not so fast and more... |
| 2017-08-01 12:15 | | Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo and more... |
| 2017-08-01 00:15 | | Express Scripts shuts out 64 branded drugs from 2018 formulary and more... |
